Achilles Therapeutics plc (ACHL) DCF Valuation

Valoración de DCF de Achilles Therapeutics PLC (ACHL)

GB | Healthcare | Biotechnology | NASDAQ
Achilles Therapeutics plc (ACHL) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Achilles Therapeutics plc (ACHL) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

¡Simplifique la valoración de Achilles Therapeutics PLC (ACHL) con esta calculadora DCF personalizable! Con el Real Achilles Therapeutics PLC (ACHL) Financials y las entradas de pronóstico ajustables, puede probar escenarios y descubrir el valor razonable de Achilles Therapeutics PLC (ACHL) en minutos.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -13.5 -33.0 -57.8 -78.4 -70.4 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation .3 .8 3.3 3.7 4.7 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -13.8 -33.7 -61.1 -82.1 -75.2 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash 97.6 177.8 266.3 173.3 131.5 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 4.5 7.3 11.2 16.0 10.4
Account Receivables, % 100 100 100 100 100
Inventories .5 1.8 5.1 4.6 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable .9 6.3 3.7 5.2 5.6 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure -.9 -11.8 -7.6 -7.5 -1.1 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % -0.7098 -0.7098 -0.7098 -0.7098 -0.7098 -0.7098 -0.7098 -0.7098 -0.7098 -0.7098
EBITAT -13.8 -33.7 -61.1 -82.2 -75.7 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -18.5 -43.5 -75.2 -88.9 -61.4 4.7 .0 .0 .0 .0
WACC, % 10.21 10.21 10.21 10.21 10.21 10.21 10.21 10.21 10.21 10.21
PV UFCF
SUM PV UFCF 4.3
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value 4
Net Debt -127
Equity Value 131
Diluted Shares Outstanding, MM 40
Equity Value Per Share 3.28

What You Will Get

  • Real ACHL Financials: Access to historical and projected data for precise valuation.
  • Customizable Inputs: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
  • Dynamic Calculations: Intrinsic value and NPV are computed automatically.
  • Scenario Analysis: Explore various scenarios to assess Achilles Therapeutics' future performance.
  • User-Friendly Design: Designed for professionals while remaining easy to use for newcomers.

Key Features

  • 🔍 Real-Life ACHL Financials: Pre-filled historical and projected data for Achilles Therapeutics plc.
  • ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) such as WACC, growth %, and tax rates.
  • 📊 Professional DCF Valuation: Built-in formulas calculate Achilles’ intrinsic value using the Discounted Cash Flow method.
  • ⚡ Instant Results: Visualize Achilles’ valuation instantly after making changes.
  • Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.

How It Works

  1. Download the Template: Gain immediate access to the Excel-based ACHL DCF Calculator.
  2. Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and other variables.
  3. Instant Calculations: The model automatically recalculates the intrinsic value of Achilles Therapeutics plc (ACHL).
  4. Test Scenarios: Experiment with different assumptions to assess potential valuation shifts.
  5. Analyze and Decide: Utilize the outcomes to inform your investment or financial strategy.

Why Choose This Calculator for Achilles Therapeutics plc (ACHL)?

  • All-in-One Solution: Integrates DCF, WACC, and financial ratio analyses tailored for Achilles Therapeutics.
  • Flexible Inputs: Modify the yellow-highlighted fields to explore different financial scenarios.
  • In-Depth Analysis: Automatically computes the intrinsic value and Net Present Value for ACHL.
  • Preloaded Information: Access to historical and projected data for reliable starting points.
  • High-Quality Standards: Perfect for financial analysts, investors, and consultants focused on the biotech sector.

Who Should Use This Product?

  • Individual Investors: Make informed decisions about buying or selling Achilles Therapeutics plc (ACHL) stock.
  • Financial Analysts: Streamline valuation processes with ready-to-use financial models for Achilles Therapeutics plc (ACHL).
  • Consultants: Deliver professional valuation insights regarding Achilles Therapeutics plc (ACHL) to clients quickly and accurately.
  • Business Owners: Understand how biotech companies like Achilles Therapeutics plc (ACHL) are valued to guide your own strategy.
  • Finance Students: Learn valuation techniques using real-world data and scenarios related to Achilles Therapeutics plc (ACHL).

What the Template Contains

  • Historical Data: Includes Achilles Therapeutics' past financials and baseline forecasts.
  • DCF and Levered DCF Models: Detailed templates to calculate Achilles Therapeutics' intrinsic value.
  • WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
  • Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
  • Quarterly and Annual Statements: A complete breakdown of Achilles Therapeutics' financials.
  • Interactive Dashboard: Visualize valuation results and projections dynamically.

No products were found matching.